Tuberculosis — metabolism and respiration in the absence of growth
The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Human tuberculosis is a complex disease caused by bacterial populations that are located in discrete lesions (microenvironments) in a single host. Some of these microenvironments are conducive to replication, whereas others restrict bacterial growth without necessarily sterilizing the infecting microorganisms. The physical and biochemical milieu in these lesions is poorly defined. None of the existing animal models for tuberculosis (except perhaps non-human primates) reproduce the diversity of disease progression that is seen in humans. Nonetheless, transcriptomics and studies using bacterial mutants have led to testable hypotheses about metabolic functions that are essential for viability in the absence of replication. A complete picture of bacterial metabolism must balance reducing equivalents while maintaining an energized membrane and basic cellular processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“M. tuberculosis harbours genes for a cytochrome c pathway consisting of a menaquinol-cytochrome c oxidoreductase termed the bc1 complex (encoded by the qcrCAB operon, complex III) and an aa3-type cytochrome c oxidase (encoded by the genes ctaBCDE, complex IV) belonging to the heme-copper respiratory oxidase family (69–71) (Table 1).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [69]
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847 · cited 1×
“tuberculosis encodes four glucose-6-phosphate dehydrogenases — two of which require NADPH as the electron donor ( zwf1 , zwf2 ), whereas fgd1 and fgd2 encode F 420 -requiring dehydrogenase”
BackgroundSelf-citationExploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828 · cited 1×
“However, tumour cells are able to adjust their metabolism to adapt to anaerobic condition”
BackgroundThe Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469 · cited 1×
“3 ), whereas higher concentrations might reach other sensitive intracellular target”
BackgroundTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Betts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180 · cited 1×
“tuberculosis during the chronic stage of the disease in mice is largely dependent on production of nitric oxide and other REACTIVE NITROGEN INTERMEDIATES (RNI), with decreased production of RNIs leading to reactivation of diseas”
BackgroundWayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Research works printed but not linked: 4
- Jagirdar, J. & Zagzag, D. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 323–344 (Lippincott Williams & Wilkins, Philadelphia, 2004). A good current and historical overview of the pathology of different forms of tuberculosis in humans.
- Daley, C. L. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 85–99 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Condos, R. & Rom, W. N. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 285–299 (Lippincott Williams & Wilkins, Philadelphia, 2004).
- Garay, S. M. in Tuberculosis (eds Rom, W. N. & Garay, S. M.) 345–394 (Lippincott Williams & Wilkins, Philadelphia, 2004). A review of the clinical aspects of pulmonary tuberculosis with well-documented case studies of reactivation disease.
Cited by
Items 301–400 of 452
Dissecting Regulatory Networks in Host-Pathogen Interaction Using ChIP-on-chip Technology
Sala, C., Grainger, D. C., & Cole, S. T. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.007 · Cited by 18
“Moreover, M. tuberculosis often enters the nonreplicating latent state (Boshoff and Barry, 2005; Wayne and Sohaskey, 2001), which has been modeled in several ways and studied by means of transcriptomics (Betts et al., 2002; Voskuil, 2004; Voskuil et al., 2004).”
BackgroundPotential of Mycobacterium tuberculosis Type II NADH-Dehydrogenase in Antitubercular Drug Discovery
Saha, P., Kumar, M., & Sharma, D. K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01005 · Cited by 14
Pieroni, M., Lilienkampf, A., Wang, Y., Wan, B., Cho, S., Franzblau, S. G., & Kozikowski, A. P. (2010) · ChemMedChem · doi:10.1002/cmdc.201000169 · Cited by 13
Maroz, A., Shinde, S. S., Franzblau, S. G., Ma, Z., Denny, W. A., Palmer, B. D., & Anderson, R. F. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b915877d · Cited by 13
Convergence and divergence in the metabolic network of Mycobacterium tuberculosis
Hubert, C. B., & de Carvalho, L. P. S. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100384 · Cited by 15
Kumar, R. P., Singh, N., Chauhan, A., Kumar, M., Bhatta, R. S., & Singh, S. K. (2022) · The Journal of Antibiotics · doi:10.1038/s41429-022-00534-6 · Cited by 13
“Mtb’s ability to sense the host environment and some of the Mtb cells enter into non-replicating persistence [2, 3].”
BackgroundShi, K.-X., Wu, Y.-K., Tang, B., Zhao, G.-P., & Lyu, L.-D. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2018.1559706 · Cited by 15
Srivastava, S., Cirrincione, K. N., Deshpande, D., & Gumbo, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.616294 · Cited by 12
Banerjee, U., Sankar, S., Singh, A., & Chandra, N. R. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.593497 · Cited by 12
“Mtb goes through extensive metabolic remodeling to achieve the non-replicative yet viable state during latency (Boshoff and Barry, 2005; Schubert et al., 2015; Baker and Abramovitch, 2018).”
BackgroundCanales, C. S. C., Cazorla, J. I. M., Cazorla, R. M. M., dos Santos, A. M., Duarte, J. L., Nunes, L. O. C., Reis, T. C., Salvador, L. C., Santos‐Filho, N. A., Sábio, R. M., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503964 · Cited by 11
“It is a slow-growing, acid-fast bacillus with a lipid-rich cell envelope and a facultative intracellular lifestyle, features that complicate macrophage-mediated clearance [25].”
Lin, P. L., Kirschner, D. E., & Flynn, J. L. (2005) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2005.05.019 · Cited by 11
Jiang, J. H., Chen, L., Zhang, J., Wang, Y., Shen, L., Yang, K., Xiao, W., Li, Y., Zhang, L., & Liu, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01359 · Cited by 15
“WhiB4 (MMAR_5170) is an oxygen-sensitive transcription factor and has been shown to regulate PE/PPE family proteins, and it plays a role in M. marinum virulence (Chawla et al., 2012; Wu et al., 2017).”
BackgroundTargeting the cytochrome bc1 complex for drug development in M. tuberculosis: review
Wani, M. A., & Dhaked, D. K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10335-y · Cited by 11
“smegmatis has an adaptation that allows it to live in the absence of cytochrome bc1-aa3 by using the cytochrome bd oxidase for energy generation [66, 67].”
BackgroundMolecular Mechanisms of Drug Tolerance in Mycobacterium tuberculosis
Антонова, А. В., Gryadunov, D. A., & Zimenkov, D. V. (2018) · Molecular Biology · doi:10.1134/s0026893318030020 · Cited by 12
“In an oxygen-deficient environment, MBT cells are capable of switching to respiration using nitrate as a terminal electron acceptor [64].”
MethodEffects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs
Coleman, D., Waddell, S. J., & Mitchison, D. A. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq414 · Cited by 12
Autofluorescence of Mycobacteria as a Tool for Detection of Mycobacterium tuberculosis
Patiño, S., Alamo, L., Cimino, M., Casart, Y., Bartoli, F., García, M. J., & Salazar, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02183-08 · Cited by 59
The Mycobacterium tuberculosis H37Ra gene MRA_1916 causes growth defects upon down-regulation
Singh, K. S., & Singh, S. K. (2015) · Scientific Reports · doi:10.1038/srep16131 · Cited by 11
Rao, S. P. S., Camacho, L. R., Tan, B. H., Boon, C., Russell, D. G., Dick, T., & Pethe, K. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01193.x · Cited by 12
“…is that viable nonreplicating bacilli reside within fibrotic granulomatous lesions within the lung and are maintained in a dormant state through conditions such as low oxygen tension and nutrient limitation (Wayne & Sramek, 1994; Wayne & Sohaskey, 2001; Betts et al., 2002; Boshoff & Barry, 2005).”
BackgroundButov, D., Kuzhko, M., Kalmykovа, I. М., Kuznetsova, I. M., Butova, T., Grinishina, O. О., & Maksimenko, O. А. (2014) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2014.02.003 · Cited by 10
“In 1993 the World Health Organization declared tuberculosis (TB) as a global epidemic [2].”
BackgroundBhargavi, G., Hassan, S., Subramanyam, B., Tripathy, S. P., & Palaniyandi, K. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01763-1 · Cited by 10
“With the increase in multidrug and extensive drug-resistance TB, there is a need to develop newer diagnostics and vaccines [3].”
BackgroundMoise, L., McMurry, J. A., & Groot, A. S. D. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369408-9.00060-3 · Cited by 10
Physiology of Mycobacterium tuberculosis
Warner, D. F., & Mizrahi, V. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch3 · Cited by 10
Yan, S., Zhen, J., Li, Y., Huang, Y., Ai, X., Li, Y., Stojkoska, A., Huang, X. S., Ruan, C., Li, J., et al. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.06.018 · Cited by 9
Tuberculosis and lung cancer: metabolic pathways play a key role
Ferdosnejad, K., Zamani, M. S., Soroush, E., Fateh, A., Siadat, S. D., & Tarashi, S. (2024) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2024.2308522 · Cited by 11
Gao, C., Sun, D., Yang, F., Tian, Z., Liu, W., & Peng, Y. (2024) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2024.105329 · Cited by 9
Płocińska, R., Wasik, K., Płociński, P., Lechowicz, E., Antczak, M., Błaszczyk, E., Dziadek, B. R., Słomka, M., Rumijowska-Galewicz, A., & Dziadek, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.909507 · Cited by 12
“Menaquinol-cytochrome c oxidoreductase (bc1), encoded by qcrCAB, and aa3-cytochrome c oxidase, encoded by ctaBCDE, belong to the heme-copper respiratory oxidase family (Boshoff and Barry, 2005;Matsoso et al., 2005; Megehee et al., 2006).”
BackgroundSingh, A., Shee, S., Reshma, T. V., Mohanraj, K., Malhotra, N., Bandopadhyay, D., Bandopadhyay, D., Beig, H., Birua, S., Niphadkar, S., et al. (2023) · eLife · doi:10.7554/elife.80218 · Cited by 10
Temporal expression ofMycobacterium smegmatisrespiratory terminal oxidases
Megehee, J. A., & Lundrigan, M. D. (2007) · Canadian Journal of Microbiology · doi:10.1139/w06-140 · Cited by 9
Design, Synthesis and Evaluation of Fe-S Targeted Adenosine 5′-Phosphosulfate Reductase Inhibitors
Paritala, H., Suzuki, Y., & Carroll, K. S. (2015) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.978012 · Cited by 8
“Numerous studies indicate that mycobacteria confront a generally hostile, anoxic and nutrient poor environment within the granuloma [7, 8].”
BackgroundThe potential of imaging tools as correlates of infection and disease for new TB vaccine development
Malherbe, S. T., Kleynhans, L., & Walzl, G. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.06.001 · Cited by 8
Ramírez, L. M. N., Mehaffy, C., & Dobos, K. M. (2018) · InTech eBooks · doi:10.5772/intechopen.69594 · Cited by 8
Phong, W. Y., Lin, W., Rao, S. P. S., Dick, T., Alonso, S., & Pethe, K. (2013) · PLoS ONE · doi:10.1371/annotation/7197763f-327f-4d6c-89fd-fba317e52c18 · Cited by 8
Experimental selection of long‐term intracellular mycobacteria
Vázquez, C. L., Lerner, T. R., Kasmapour, B., Pei, G., Gronow, A., Bianco, M. V., Blanco, F. C., Bleck, C. K. E., Geffers, R., Bigi, F., et al. (2014) · Cellular Microbiology · doi:10.1111/cmi.12303 · Cited by 8
“A switch in carbon-source usage is postulated for bacteria that changed from an extra- to an intracellular niche (Boshoff and Barry, 2005; Eisenreich et al., 2010).”
BackgroundEvangelopoulos, D., Cronin, N., Daviter, T., Sim, E., Keep, N. H., & Bhakta, S. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08382.x · Cited by 7
The Effects of Carbon Source and Growth Temperature on the Fatty Acid Profiles of Thermobifida fusca
Winkelman, D. C., & Nikolau, B. J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.896226 · Cited by 7
“, 2005), a process that has previously been explored in Mycobacterium tuberculosis (Boshoff and Barry, 2005; Watanabe et al., 2011; Katiyar et al., 2018).”
BackgroundGutka, H. J., Franzblau, S. G., Movahedzadeh, F., & Abad‐Zapatero, C. (2011) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309111014722 · Cited by 7
“Although Mtb is capable of growth on a variety of substrates in vitro, there is evidence that suggests that during infection Mtb preferentially utilizes fatty acids as a source of energy (Boshoff & Barry, 2005).”
BackgroundDuncan, C. L., Jamieson, F., Troudt, J. M., Izzo, L. S., Bielefeldt‐Ohmann, H., Izzo, A. A., & Mehaffy, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179996 · Cited by 7
CarD Tricks and Magic Spots: Mechanisms of Stringent Control in Mycobacteria
Connolly, L. E., & Cox, J. S. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.07.001 · Cited by 7
“Lack of vital nutrients, oxygen, and iron is thought to restrict bacterial replication during infection (Boshoff and Barry, 2005).”
BackgroundGoodwin, M. B., Boshoff, H. I., Barry, C. E., & Dowd, C. S. (2006) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2745 · Cited by 7
Self-citationCentral Metabolism of Species of the Genus Rhodococcus
Hernández, M. A., Álvarez, H. M., Lanfranconi, M. P., Silva, R. A., Herrero, O. M., & Villalba, M. S. (2019) · Microbiology monographs · doi:10.1007/978-3-030-11461-9_3 · Cited by 6
Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis
Abo-Kadoum, M. A., Dai, Y., Asaad, M., Hamdi, I., & Xie, J. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0179 · Cited by 6
Allostery and compartmentalization: old but not forgotten
Eoh, H., & Rhee, K. Y. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.01.007 · Cited by 6
“Of particular significance is its ability to maintain viability for prolonged periods of time in noxious and nutrient-poor environments, yet preserve the capacity to resume replication and transmit itself to a new host [5,17,43].”
BackgroundGordhan, B. G., Peters, J. S., & Kana, B. D. (2019) · Advances in applied microbiology · doi:10.1016/bs.aambs.2019.08.001 · Cited by 6
Structural and DNA binding properties of mycobacterial integration host factor mIHF
Odermatt, N. T., Lelli, M., Herrmann, T., Abriata, L. A., Japaridze, A., Voilquin, H., Singh, R., Piton, J., Emsley, L., Dietler, G., et al. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.107434 · Cited by 7
Singh, S., Ng, P. S., Lakshmanan, U., Mathiyazakan, V., Wiggins, T. J., Lee, B. S., Ang, S. H., Sim, S. W. L., Santos, M. D., Moraski, G. C., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01616 · Cited by 5
Advancing roles of nitric oxide in tuberculosis: Promising targets for novel anti-TB therapeutics
Kong, X., Yang, J., Wang, J., Li, J., Jin, X., Cai, J., Ruan, Y., Chen, R., Shen, L., & Pi, J. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128292 · Cited by 6
Yongyat, C., Ruchirawat, S., & Boonyarattanakalin, S. (2014) · e-Polymers · doi:10.1515/epoly-2014-0129 · Cited by 5
Yeware, A. M., Akhtar, S., & Sarkar, D. M. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100115 · Cited by 6
Redox cofactors insertion in prokaryotic molybdoenzymes occurs via a conserved folding mechanism
Arias-Cartín, R., Ceccaldi, P., Schoepp‐Cothenet, B., Frick, K., Blanc, J.-M., Guigliarelli, B., Walburger, A., Grimaldi, S., Friedrich, T., Receveur‐Brechot, V., et al. (2016) · Scientific Reports · doi:10.1038/srep37743 · Cited by 5
Pardeshi, P., Rao, K. K., & Balaji, P. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175193 · Cited by 6
Sharma, S., Bhat, R., Singh, R., Sharma, S., Wazir, P., Singh, P. P., Vishwakarma, R. A., & Khan, I. A. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101958 · Cited by 6
Targeting Phenotypically Tolerant Mycobacterium tuberculosis
Gold, B. S., & Nathan, C. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch15 · Cited by 8
Bhat, S. A., Iqbal, I. K., & Kumar, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7680-5_14 · Cited by 4
Das, R., Eniyan, K., & Bajpai, U. (2021) · Immunogenetics · doi:10.1007/s00251-021-01220-x · Cited by 4
Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
Hazra, S., Hazarika, R., & Patra, S. (2023) · Current Drug Targets · doi:10.2174/1389450124666230505145335 · Cited by 4
Devasundaram, S., & Raja, A. (2016) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2016.01.007 · Cited by 4
Exploring Aspartate Transcarbamoylase: A Promising Broad‐Spectrum Target for Drug Development
Chen, S., Mondile, Q., Du, X., Wang, C., Shashikant, M. M., Wrenger, C., Dömling, A. S. S., Bishop, Ö. T., & Groves, M. R. (2025) · ChemBioChem · doi:10.1002/cbic.202401009 · Cited by 3
Approaches to clinical trials of new anti-TB drugs
Bark, C. M., Furin, J. J., & Johnson, J. L. (2012) · Clinical Investigation · doi:10.4155/cli.12.22 · Cited by 3
Navarro, J., & Marijuán, P. C. (2011) · tripleC Communication Capitalism & Critique Open Access Journal for a Global Sustainable Information Society · doi:10.31269/triplec.v9i2.292 · Cited by 3
Measuring Microbial Metabolism in Atypical Environments
Stone, W., & Wolfaardt, G. M. (2018) · Methods in microbiology · doi:10.1016/bs.mim.2018.07.004 · Cited by 3
Proton Motive Force-Disrupting Antimycobacterial Guanylurea Polymer
Miranda-Velez, M., Sarker, G. S., Ramisetty, P., Geden, S. E., Halicki, P. C. B., Annamalai, T., Tse‐Dinh, Y., Rohde, K. H., & Moon, J. H. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00902 · Cited by 3
Respiration and Oxidative Phosphorylation in Mycobacteria
Berney, M., & Cook, G. M. (2014) · Advances in photosynthesis and respiration · doi:10.1007/978-94-017-8742-0_15 · Cited by 4
Mechanisms of Latent Tuberculosis: Dormancy and Resuscitation of Mycobacterium tuberculosis
Mukamolova, G. V., Salina, E. G., & Kaprelyants, A. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-569-5_10 · Cited by 5
Barman, A., Patra, M. M., & GUPTA, S. K. (2022) · Microbiology · doi:10.1099/mic.0.001192 · Cited by 3
Physiological roles of the three [NiFe]-hydrogenases in Mycobacterium smegmatis
Greening, C. A. (2013) · Otago University Research Archive (University of Otago) · doi:10.13140/2.1.1381.1841 · Cited by 4
Rehan, A. M., Bashiri, G., Paterson, N. G., Baker, E. N., & Squire, C. J. (2011) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309111028958 · Cited by 2
“The cofactor F420 is a flavin analogue that is essential for methanogenesis in archaea and is hypothesized to be important in the pathogenesis of Mycobacterium tuberculosis as a ‘hydride carrier’ owing to its lower redox potential compared with NAD(P)+ (Boshoff & Barry, 2005).”
BackgroundThe Physiology and Genetics of Oxidative Stress in Mycobacteria
Cumming, B. M., Lamprecht, D. A., Wells, R. M., Saini, V., Mazorodze, J. H., & Steyn, A. J. C. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch15 · Cited by 3
The Role of Hypoxia-inducible Factor in Mycobacterium tuberculosis-infected Macrophages
Fitriana, N., Iswanti, F. C., & Sadikin, M. (2024) · Molecular and Cellular Biomedical Sciences · doi:10.21705/mcbs.v8i1.405 · Cited by 3
Kotzé, T. J., Mostert, K. J., Domingo, R., Wang, X., Moolman, W. J. A., Butman, H. S., Pepin, A., McKay, K. T., Neveling, D. P., Evans, J. C., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00047 · Cited by 2
Mycobacterium tuberculosis Metabolism
Mashabela, G. T., de Wet, T. J., & Warner, D. F. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch67 · Cited by 3
Pérez-Martínez, D. E., Mejía‐Ponce, P. M., Licona‐Cassani, C., de Igartua, E., Bermúdez, G., Viveros, D., & Zenteno‐Cuevas, R. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_18 · Cited by 2
THE PECULARITIES OF TUBERCULOSIS, CAUSED BY BEIJING STRAINS
Чеснокова, М. М., Bazhora, Y. І., Antonenko, K., & Остапчук, К. В. (2023) · Odes’kij medičnij žurnal (The Odessa Medical Journal) · doi:10.54229/2226-2008-2022-1-2-10 · Cited by 2
Sorokoumova, G. M., Андреевская, С. М., Смирнова, Т. Г., Petrova, E. E., Zhogina, Y. A., Kalashnikova, T. Y., Черноусова, Л. Н., Селищева, А. А., & Швец, В. И. (2009) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-0819-1 · Cited by 2
Immunopathology of Tuberculosis Disease across Species
Dartois, V. A. (2010) · CRC Press eBooks · doi:10.1201/ebk1439835272-5 · Cited by 2
Mycobacterium tuberculosis and His Comrades
Schaible, U. E. (2009) · Wiley eBooks · doi:10.1002/9783527629176.ch19 · Cited by 4
The Medicinal Chemistry of Novel Molecules in Clinical Trials for Tuberculosis Treatment
Branco, F. S. C., Pinto, A. C., & Boechat, N. (2012) · Revista Virtual de Química · doi:10.5935/1984-6835.20120023 · Cited by 2
Savalas, L. R. T., Sedijani, P., Hadisaputra, S., ‘Ardhuha, J., Lestari, C. A., & Wahidah, E. N. (2017) · Biosaintifika Journal of Biology & Biology Education · doi:10.15294/biosaintifika.v9i3.12384 · Cited by 2
“They can maintain viability in dormant phase in a different environment (Boshoff & Barry, 2005) whereas others restrict bacterial growth without necessarily sterilizing the infecting microorganisms.”
BackgroundDrug Susceptibility of Individual Mycobacterial Cells
Boot, M., & Rego, E. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-25241-0_11 · Cited by 2
Host–Pathogen Interactions Influencing Mycobacterium tuberculosis Persistence and Drug Tolerance
Zheng, H., & Abramovitch, R. B. (2019) · Springer eBooks · doi:10.1007/978-3-030-25241-0_10 · Cited by 2
Energy Pathways in Mycobacterium Tuberculosis
Ganeshpurkar, A., Singh, R. P., Singh, M., Kumar, A., & Singh, S. K. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_25 · Cited by 2
Low dose BCG vaccination in mice : immune responses and implications for tuberculosis control
Kiros, T. G. G. (2007) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 3
The Proteome of Mycobacterium tuberculosis in Three Dimensions
Wilmanns, M., & Kaufmann, S. H. E. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch12 · Cited by 2
Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria
Courbon, G. M., Makarov, V., Cole, S. T., Schnapinger, D., Ehrt, S., & Rubinstein, J. L. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00726-y · Cited by 1
“The use of cholesterol and fatty acids as a carbon source in granulomas, where other nutrients are scarce, could play an important role in persistence (Boshoff and Barry, 2005; Russell et al, 2009).”
Abbadi, B. L., Barth, V. C., Sain, S., Puffal, J., Zeng, J., Patel, P. K., Husson, R. N., & Woychik, N. A. (2026) · mSystems · doi:10.1128/msystems.01814-25 · Cited by 3
Ahmad, S., Rahman, H., Akram, M. S., Mehboob, J., Thomas, G. H., Alzahrani, K. J., Alsharif, K. F., & Alzahrani, F. M. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108500 · Cited by 1
Kumar, R., Roy, A., Kalia, N. P., & Sharma, D. K. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.146801 · Cited by 1
Kaur, P., Sharma, S., Abhishek, S., Aggarwal, A. N., Kaur, K., Yadav, R., Sethi, S. K., Bal, A., & Verma, I. (2026) · Scientific Reports · doi:10.1038/s41598-026-42637-2 · Cited by 1
Eniyan, K., & Bajpai, U. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60181-4 · Cited by 2
“tuberculosis relies heavily on fatty acid metabolism for both energy supply and for synthesis of essential biomolecules required for its growth and survival in the living host[1-3].”
BackgroundÁlvarez, N., Borrero, R., Reyes, F., Camacho, F., Mohd, N., Sarmiento, M. E., & Acosta, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5
The challenge of new drug discovery for
Arnoult, É., Lounis, N., Guillemont, J., & Andries, K. (2011) · Cited by 1
Molecular Docking Studies of PA-824 with Pyridoxine 5'-Phosphate Oxidase
Sathish Kumar, M., & Jaleel, U. C. A. (2015) · Biology and Medicine · doi:10.4172/0974-8369.1000274 · Cited by 1
Virulence and Persistence Mechanisms of Mycobacterium tuberculosis
Boshoff, H. I., Singh, R., & Barry, C. E. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch8 · Cited by 3
Self-citationGenomics of the Mycobacterium tuberculosis Complex
Gordon, S. V., & Pym, A. S. (2008) · Wiley eBooks · doi:10.1002/9783527611614.ch9 · Cited by 1
Fighting Fire with Fire: Computational Prediction of Microbial Targets for Bacteriocins
Coelho, E. D., Arrais, J. P., & Oliveira, J. L. (2018) · Lecture notes in computer science · doi:10.1007/978-3-319-78723-7_19 · Cited by 1
Jeon, A. B., Basaraba, R. J., Borlee, B., Gustafson, D., Jackson, M., Melander, C., & Obregón-Henao, A. (2017) · Digital Collections of Colorado (Colorado State University) · doi:10.25675/3.020311 · Cited by 1
Nesci, S. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.01.006 · Cited by 1
Multiomics Integration of Tuberculosis Pathogenesis
Lee, J. J., Sell, P., & Eoh, H. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_45 · Cited by 1
Diagnostic Challenge of Tuberculosis Heterogeneity
Nemes, E., Meermeier, E. W., Scriba, T. J., Walzl, G., Malherbe, S. T., & Lewinsohn, D. M. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1660471 · Cited by 1
Clifton E. Barry, III: TB's strategic opponent
Maxmen, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.2063pi · Cited by 1
Metadata
- Authors
- Boshoff, H. I. M., & Barry, C. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Boshoff, Helena I. M.
- Venue
- Nature Reviews Microbiology
- Published
- 2005-01
- Volume
- 3
- Issue
- 1
- Pages
- 70-80
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1973789730
- Cited by
- 448
- References
- 88
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 11 · 2023: 11 · 2022: 9 · 2021: 17 · 2020: 20 · 2019: 22 · 2018: 21 · 2017: 22 · 2016: 20 · 2015: 35 · 2014: 30 · 2013: 24 · 2012: 26
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI000783)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis, Mycobacterium tuberculosis, bacterial metabolism, respiration, non-replicating persistence, animal models of tuberculosis, transcriptomics, bacterial mutants, reducing equivalents, membrane potential, bacterial viability
- MeSH terms
- Adaptation, Physiological, Animals, Citric Acid Cycle, Gluconeogenesis, Humans, Mycobacterium tuberculosis, Oxidation-Reduction, Oxygen Consumption, Riboflavin, Tuberculosis, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.